Veracyte Inc

Common Name
Veracyte
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
824
Ticker
VCYT
Exchange
NASDAQ/NMS
Description
Veracyte Inc. is a genomic diagnostics company specializing in advanced molecular diagnostic tests that address critical healthcare needs. The primary function of Veracyte is to improve patient outcom...

Veracyte's GHG Emissions Data Preview

In 2023, Veracyte completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Veracyte has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Veracyte’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Veracyte’s data sources below and access millions more through our Disclosure Search.

a. Veracyte's ESG Report 2024
a. Veracyte's ESG Report 2024

Insights into Veracyte's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Veracyte amounted to 1,127 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Veracyte's Scope 1 Emissions Over Time

20230150300450600tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Veracyte's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Veracyte were 448 metric tons of CO₂ equivalent (tCO₂e). a

What are Veracyte's Scope 2 emissions?

In 2023, Veracyte reported Scope 2 greenhouse gas (GHG) emissions of 679 tCO₂e without specifying the calculation method. a

What methodology does Veracyte use for Scope 2 reporting?

In 2023, Veracyte reported its Scope 2 emissions using an unspecified methodology. a

Veracyte's Scope 2 Emissions Over Time

20230200400600800tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Veracyte’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Veracyte reported Scope 1 greenhouse gas (GHG) emissions of 448 tCO₂e and total revenues of USD 361 millions. This translates into an emissions intensity of 1.24 tCO₂e per millions USD. a

Veracyte's Scope 1 Emissions Intensity Compared to Peers

51002,00050,0001,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)RTIQVIA HoldingsYear: 2023Scope 1: 8,221 tCO2eRevenue: $M 14,983Scope 1 Intensity: 0.55 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MExact SciencesYear: 2024Scope 1: 12,121 tCO2eRevenue: $M 2,759Scope 1 Intensity: 4.39 tCO2e/$MDanaherYear: 2024Scope 1: 109,046 tCO2eRevenue: $M 23,875Scope 1 Intensity: 4.57 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MQuest DiagnosticsYear: 2021Scope 1: 238,910 tCO2eRevenue: $M 10,788Scope 1 Intensity: 22.15 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MThermo Fisher ScientificYear: 2024Scope 1: 315,843 tCO2eRevenue: $M 42,879Scope 1 Intensity: 7.37 tCO2e/$MRRRevvityYear: 2023Scope 1: 2,121 tCO2eRevenue: $M 2,751Scope 1 Intensity: 0.77 tCO2e/$MTTTwist BioscienceYear: 2024Scope 1: 7 tCO2eRevenue: $M 313Scope 1 Intensity: 0.02 tCO2e/$MCharles River LaboratoriesYear: 2023Scope 1: 85,957 tCO2eRevenue: $M 4,129Scope 1 Intensity: 20.82 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MIDEXX LaboratoriesYear: 2024Scope 1: 18,461 tCO2eRevenue: $M 3,898Scope 1 Intensity: 4.74 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MNateraYear: 2024Scope 1: 5,143 tCO2eRevenue: $M 1,697Scope 1 Intensity: 3.03 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$M

How does Veracyte's GHG emissions intensity compare to its peers?

In 2023, Veracyte reported a Scope 1 emissions intensity of 1.24 tCO₂e per millions USD. Compared to the peer group median of 3.28 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Veracyte rank on GHG emissions intensity within its industry?

In 2023, Veracyte ranked 7 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Veracyte is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Veracyte's GHG Emissions Dataset?
Sign Up